Viewing Study NCT07193394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-01-28 @ 4:50 PM
Study NCT ID: NCT07193394
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-25
First Post: 2025-09-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer
Sponsor: Institut Curie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer ( HER2 Negative) View
None Unresectable Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast View
None Cancer View
None HER2 View
None tucatinib View
None trastuzumab View
None HER3 View
None metastatic View
None unresectable View